Question 1

What is the analyst consensus rating for PTGX?

Accepted Answer

The analyst consensus rating for PTGX is "Strong Buy" based on 5 analyst recommendations.

Question 2

What is the average price target for PTGX?

Accepted Answer

The average 12-month price target for PTGX is $113.60, representing an upside of 37.8% from the current price of $82.46.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Feb 2, 2026	Roger Song	Jefferies	Maintains	Strong Buy	$95.00 → $118.00 +23.00 (24.2%)
Jan 30, 2026	Douglas Tsao	HC Wainwright	Maintains	Strong Buy	$80.00 → $117.00 +37.00 (46.3%)
Jan 5, 2026	Srikripa Devarakonda	Truist	Maintains	Strong Buy	$88.00 → $110.00 +22.00 (25.0%)
Dec 17, 2025	Etzer Darout	Barclays	Maintains	Buy	$88.00 → $108.00 +20.00 (22.7%)
Dec 8, 2025	Geoff Meacham	Citi	Maintains	Strong Buy	$98.00 → $115.00 +17.00 (17.4%)

Protagonist Therapeutics (PTGX) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest PTGX Analyst Ratings & Recommendations